Date: 23-Jul-2019

Dr. Reddys Labs launches generic Allegra-D in US market

Dr. Reddys Laboratories Ltd along with its subsidiaries announced the launch of fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg extended-release tablets, USP, an over-the-counter (OTC) store-brand equivalent of Allegra-D 12 HR allergy and congestion extended-release tablets, in the United States market, as approved by the US Food and Drug Administration (FDA).